- Title
- Clinical trial : interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C
- Creators
- J. G MCHUTCHISON - Division of Gastroenterology, Gastrointestinal/Hepatology Research Program, Duke Clinical Research Institute, Durham, NC, United StatesK PATEL - Division of Gastroenterology, Duke University Medical Center, Durham, NC, United StatesJ HARVEY - Schering-Plough Research Institute, Kenilworth, NJ, United StatesJ. K ALBRECHT - Schering-Plough Research Institute, Kenilworth, NJ, United StatesE. R SCHIFFT - Division of Hepatology, University of Miami School of Medicine, Miami, FL, United StatesN GITLIN - Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, United StatesR. E MUR - Servicio de Hepatologia, Hospital Valle de Hebron, Barcelona, SpainG. T EVERSON - Section of Hepatology, University of Colorado Health Sciences Center, Denver, CO, United StatesR. L CARITHERS - University of Washington Medical Center, Seattle, WA, United StatesG. L DAVIS - university of Florida School of Medicine, Gainesville, FL, United StatesP MARCELLIN - Service d'Heptologie, Hopital Beaujon, Clichy, FranceM. L SHIFFMAN - Hepatology Section, Virginia Commonwealth University Health System, Richmond, VA, United States
- Publication Details
- Alimentary pharmacology & therapeutics, Vol.27(5), pp.422-432
- Publisher
- Blackwell; Oxford
- Language
- English
- Resource Type
- Journal article
- PMID
- 18081733
- Record Identifier
- 991031575628402976
Journal article
Clinical trial : interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C
Alimentary pharmacology & therapeutics, Vol.27(5), pp.422-432
2008
PMID: 18081733
Metrics
4 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.125 Hepatitis
- 1.125.83 HCV
- Web Of Science research areas
- Gastroenterology & Hepatology
- Pharmacology & Pharmacy
- ESI research areas
- Pharmacology & Toxicology
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites